Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial Completed
614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study